Scientists create new cell lines from ocular melanoma patients

Mar 11, 2011

Researchers at UCLA's Jules Stein Eye Institute have created new tumor cell lines from fine-needle biopsies of ocular melanoma patients who had undergone treatment but died when their cancer spread aggressively.

These new cell lines will afford scientists valuable insights into how the eye cancer causes rapid metastasis. The findings could lead to new methods for testing drugs for treatment.   

Until now, scientists have had a limited number of models for studying ocular . The cancer does not naturally occur in animals, and commercially available may differ from the original

"Each cell line retained the molecular features found in its original tumor," said principal investigator Dr. Tara McCannel. "That's important, because the more closely a model resembles the actual tumor, the more likely that discoveries made using the model are to be valid."

Ocular melanoma, which forms in the pigmented layers under the retina, is the most common in adults, with approximately 2,000 new cases (seven in 1 million people) diagnosed each year. The cause remains unknown.

Patients whose tumors contain a genetic marker linked to rapid metastasis have at least a 50 percent chance of death within five years, due to swift spreading of the tumor to the liver and other organs. Particularly aggressive cases can result in blindness and death within a year.

Explore further: Prosocial internet support group not beneficial for breast cancer

More information: The research appears in the Feb. 25 online edition of the journal Molecular Vision.

add to favorites email to friend print save as pdf

Related Stories

Melanoma uses body's immune system to spread to lungs

Sep 24, 2010

(PhysOrg.com) -- The way melanoma cells use the immune system to spread and develop into lung tumors may lead to a therapy to decrease development of these tumors, according to Penn State researchers.

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

Nov 21, 2014

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

Nov 21, 2014

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.